Andreas Seidl
Chief Tech/Sci/R&D Officer bij FORMYCON AG
Profiel
Andreas Seidl is currently the Chief Operating Officer at LEUKOCARE AG and the Chief Scientific Officer at Formycon AG.
He holds a doctorate degree from Universität Konstanz.
Actieve functies van Andreas Seidl
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMYCON AG | Chief Tech/Sci/R&D Officer | 01-07-2022 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Chief Operating Officer | 01-04-2019 |
Opleiding van Andreas Seidl
| Universität Konstanz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
